The role of methylprednisolone on preventing disease progression for hospitalized patients with severe COVID-19

被引:21
作者
Yang, Rongrong [1 ]
Xiong, Yong [1 ]
Ke, Hengning [1 ]
Chen, Tielong [1 ]
Gao, Shicheng [1 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Infect Dis, Donghu Rd 169, Wuhan 430071, Peoples R China
关键词
COVID-19; cytokine storm; methylprednisolone; prognosis; SARS-CoV-2; ACUTE RESPIRATORY SYNDROME; CLINICAL CHARACTERISTICS; CORTICOSTEROID TREATMENT; INFLUENZA; PNEUMONIA; MORTALITY; HYDROCORTISONE;
D O I
10.1111/eci.13412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background COVID-19 is a public health emergency that is spreading worldwide and seriously affecting the global economy. Data on the effectiveness and safety of the use of methylprednisolone for patients with severe COVID-19 remain limited. Methods In this retrospective study, epidemiological, clinical, laboratory, treatment and outcomes data of hospitalized patients with severe COVID-19 in Zhongnan Hospital of Wuhan University from January 1 to 7 March 2020, were collected. Binary logistic regression model was used to analyse risk factors for disease progression from severe COVID-19 illness to critical illness. The effectiveness and safety of the use of methylprednisolone for patients with severe COVID-19 disease were evaluated. Results The results of the multivariate analysis from 175 patients with severe COVID-19 indicate that the use of methylprednisolone was a protective factor against disease progression from severe to critical illness(P < .001; OR: 0.054 95% CI: 0.017-0.173). Among patients with severe COVID-19 aged < 65 years, both the proportion of patients who progressed to critical illness (42.2% vs 90.0%,P = .000) and the mortality(6.7% vs 30.0%,P = .002) were lower for patients in methylprednisolone group, compared with those in the non-methylprednisolone group, whereas no statistical differences between the methylprednisolone group and the non-methylprednisolone group were found among patients with COVID-19 older than 65 years. Moreover, both the levels of CD4(+)T lymphocyte counts (646 vs 463/mu L,P = .007) and IL-6 (241.9 vs 82.8 pg/mL,P = .025) were higher among patients with severe COVID-19 aged < 65 years, compared with those patients >= 65 years old. Conclusion Data from the limited sample showed that the early use of low or medium doses of methylprednisolone has a positive effect for patients with severe COVID-19 younger than 65 years old, and excessive immune response and cytokine storm may be some of the reasons for the effectiveness.
引用
收藏
页数:8
相关论文
共 34 条
  • [11] The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China
    Hui, David S.
    Azhar, Esam I.
    Madani, Tariq A.
    Ntoumi, Francine
    Kock, Richard
    Dar, Osman
    Ippolito, Giuseppe
    Mchugh, Timothy D.
    Memish, Ziad A.
    Drosten, Christian
    Zumla, Alimuddin
    Petersen, Eskild
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 91 : 264 - 266
  • [12] Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009.
    Jain, Seema
    Kamimoto, Laurie
    Bramley, Anna M.
    Schmitz, Ann M.
    Benoit, Stephen R.
    Louie, Janice
    Sugerman, David E.
    Druckenmiller, Jean K.
    Ritger, Kathleen A.
    Chugh, Rashmi
    Jasuja, Supriya
    Deutscher, Meredith
    Chen, Sanny
    Walker, John D.
    Duchin, Jeffrey S.
    Lett, Susan
    Soliva, Susan
    Wells, Eden V.
    Swerdlow, David
    Uyeki, Timothy M.
    Fiore, Anthony E.
    Olsen, Sonja J.
    Fry, Alicia M.
    Bridges, Carolyn B.
    Finelli, Lyn
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (20) : 1935 - 1944
  • [13] Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock - A double-blind, randomized, placebo-controlled, crossover study
    Keh, D
    Boehnke, T
    Weber-Cartens, S
    Schulz, C
    Ahlers, O
    Bercker, S
    Volk, HD
    Doecke, WD
    Falke, KJ
    Gerlach, H
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (04) : 512 - 520
  • [14] Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: A meta-analysis of randomized controlled trials
    Lamontagne, Francois
    Briel, Matthias
    Guyatt, Gordon H.
    Cook, Deborah J.
    Bhatnagar, Neera
    Meade, Maureen
    [J]. JOURNAL OF CRITICAL CARE, 2010, 25 (03) : 420 - 435
  • [15] Factors associated with psychosis among patients with severe acute respiratory syndrome: A case-control study
    Lee, DTS
    Wing, YK
    Leung, HCM
    Sung, JJY
    Ng, YK
    Yiu, GC
    Chen, RYL
    Chiu, HFK
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (08) : 1247 - 1249
  • [16] Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients
    Lee, N
    Chan, KCA
    Hui, DS
    Ng, EKO
    Wu, A
    Chiu, RWK
    Wong, VWS
    Chan, PKS
    Wong, KT
    Wong, E
    Cockram, CS
    Tam, JS
    Sung, JJY
    Lo, YD
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (04) : 304 - 309
  • [17] Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia
    Li, Hui
    Yang, Shi-gui
    Gu, Li
    Zhang, Yao
    Yan, Xi-xin
    Liang, Zong-an
    Zhang, Wei
    Jia, Hong-yu
    Chen, Wei
    Liu, Meng
    Yu, Kai-jiang
    Xue, Chun-xue
    Hu, Ke
    Zou, Qi
    Li, Lan-juan
    Cao, Bin
    Wang, Chen
    [J]. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2017, 11 (04) : 345 - 354
  • [18] Li Yu-ming, 2004, Zhonghua Yi Xue Za Zhi, V84, P1348
  • [19] Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California
    Louie, Janice K.
    Acosta, Meileen
    Winter, Kathleen
    Jean, Cynthia
    Gavali, Shilpa
    Schechter, Robert
    Vugia, Duc
    Harriman, Kathleen
    Matyas, Bela
    Glaser, Carol A.
    Samuel, Michael C.
    Rosenberg, Jon
    Talarico, John
    Hatch, Douglas
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (17): : 1896 - 1902
  • [20] Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
    McCreary, Erin K.
    Kullar, Ravina
    Geriak, Matthew
    Zasowski, Evan J.
    Rizvi, Khulood
    Schulz, Lucas T.
    Ouellette, Krista
    Vasina, Logan
    Haddad, Fadi
    Rybak, Michael J.
    Zervos, Marcus J.
    Sakoulas, George
    Rose, Warren E.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (01):